Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. AVROBIO, Inc.
  6. News
  7. Summary
    AVRO   US05455M1009

AVROBIO, INC.

(AVRO)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
 SummaryMost relevantAll NewsAnalyst Reco.Other languagesPress ReleasesOfficial PublicationsSector news
Most relevant news about AVROBIO, INC.
01/07AVROBIO Gets Approval to Cut 23% of Workforce
MT
01/07AVROBIO : Current Report (Form 8-K)
PU
01/06Mizuho Adjusts AVROBIO's Price Target to $6 from $28, Keeps Buy Rating
MT
01/06AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
01/05Morgan Stanley Adjusts Price Target on AVROBIO to $3 From $7, Maintains Equal-Weight Ra..
MT
01/05Needham Adjusts AVROBIO's Price Target to $8 From $28, Reiterates Buy Rating
MT
01/05BTIG Downgrades AVROBIO to Neutral From Buy
MT
01/05Barclays Adjusts AVROBIO's Price Target to $6 From $22, Reiterates Overweight Rating
MT
01/04Wedbush Lowers PT for AVROBIO to $14 From $30 As Company 'Deprioritizes' Fabry Disease ..
MT
01/04AVROBIO : Reprioritizes Pipeline Programs - Form 8-K
PU
01/04Avrobio Shifts Focus From Fabry Disease to Lysosomal Disorder; Resumes Activity After B..
MT
01/04AVROBIO : Pipeline Prioritization and Fabry Data Presentation
PU
01/04AVROBIO Reprioritizes Pipeline Programs
BU
01/04AVROBIO, Inc. Announces New Data from Phase 2 Fab-Gt Clinical Trial Show Variable Engra..
CI
2021AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
More most relevant news
All news about AVROBIO, INC.
01/07AVROBIO Gets Approval to Cut 23% of Workforce
MT
01/07AVROBIO : Current Report (Form 8-K)
PU
01/07AVROBIO, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or ..
AQ
01/06Mizuho Adjusts AVROBIO's Price Target to $6 from $28, Keeps Buy Rating
MT
01/06AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
01/06NORTH AMERICAN MORNING BRIEFING : Tech Stocks Set -3-
DJ
01/05Morgan Stanley Adjusts Price Target on AVROBIO to $3 From $7, Maintains Equal-Weight Ra..
MT
01/05Needham Adjusts AVROBIO's Price Target to $8 From $28, Reiterates Buy Rating
MT
01/05BTIG Downgrades AVROBIO to Neutral From Buy
MT
01/05Barclays Adjusts AVROBIO's Price Target to $6 From $22, Reiterates Overweight Rating
MT
More news
News in other languages on AVROBIO, INC.
01/07AVROBIO obtient l'autorisation de réduire ses effectifs de 23 %.
01/04AVROBIO, Inc. annonce que les nouvelles données de l'essai clinique de phase 2 sur Fab-..
2021Avrobio ne signale aucun effet indésirable pour les thérapies géniques AVR-RD-01 et AVR..
2021Jasper Therapeutics s'associe à Avrobio pour étudier le JSP191 sur des patients atteint..
2021AVROBIO reçoit la désignation de maladie pédiatrique rare de la FDA pour le traitement ..
2021MISE À JOUR : les actions de Bluebird Bio chutent en raison de la suspension des essais cl..
2021Avrobio déclare que l'approbation par la FDA du Fabrazyme de Sanofi laisse l'essai en t..
2021La clarté réglementaire d'Avrobio va renforcer la confiance des investisseurs, selon We..
2021AVROBIO annonce une perte plus importante au quatrième trimestre
2021La thérapie génique expérimentale d'Avrobio pour la cystinose obtient la désignation de..
More news
Analyst Recommendations on AVROBIO, INC.
01/06Mizuho Adjusts AVROBIO's Price Target to $6 from $28, Keeps Buy Rating
MT
01/05Morgan Stanley Adjusts Price Target on AVROBIO to $3 From $7, Maintains Equal-Weight Ra..
MT
01/05Needham Adjusts AVROBIO's Price Target to $8 From $28, Reiterates Buy Rating
MT
01/05BTIG Downgrades AVROBIO to Neutral From Buy
MT
01/05Barclays Adjusts AVROBIO's Price Target to $6 From $22, Reiterates Overweight Rating
MT
More recommendations
Press releases
01/07AVROBIO : Current Report (Form 8-K)
PU
01/07AVROBIO, INC. : Costs Associated with Exit or Disposal Activities, Change in Directors or ..
AQ
01/06AVROBIO Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
BU
01/04Ford, Hess rise; Blackbaud, Avrobio fall
AQ
01/04AVROBIO : Reprioritizes Pipeline Programs - Form 8-K
PU
More press releases
Upcoming event on AVROBIO, INC.